Veeder M - Search Results

1

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

Hong D, Rasco D, Veeder M, Luke JJ, Chandler J, Balmanoukian A, George TJ, Munster P, Berlin JD, Gutierrez M, Mita A, Wakelee H, Samakoglu S, Guan S, Dimery I, Graef T, Borazanci E. Hong D, et al. Among authors: veeder m. Oncology. 2019;97(2):102-111. doi: 10.1159/000500571. Epub 2019 Jun 21. Oncology. 2019. PMID: 31230047 Free article. Clinical Trial.

2

A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.

Perez EA, Suman VJ, Fitch TR, Mailliard JA, Ingle JN, Cole JT, Veeder MH, Flynn PJ, Walsh DJ, Addo FK. Perez EA, et al. Among authors: veeder mh. Oncology. 2005;69(2):117-21. doi: 10.1159/000087813. Epub 2005 Aug 23. Oncology. 2005. PMID: 16118507 Clinical Trial.

3

A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma.

Creagan ET, Veeder MH, Suman VJ, Burch PA, Maples WJ, Schaefer PL, Pfeifle DM, Dalton RJ, Hatfield AK, Poon MA. Creagan ET, et al. Among authors: veeder mh. Am J Clin Oncol. 1998 Oct;21(5):475-8. doi: 10.1097/00000421-199810000-00011. Am J Clin Oncol. 1998. PMID: 9781603 Clinical Trial.

4

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group.

Jett JR, Everson L, Therneau TM, Krook JE, Dalton RJ, Marschke RF Jr, Veeder MH, Brunk SF, Mailliard JA, Twito DI, et al. Jett JR, et al. Among authors: veeder mh. J Clin Oncol. 1990 Jan;8(1):33-8. doi: 10.1200/JCO.1990.8.1.33. J Clin Oncol. 1990. PMID: 2153193 Clinical Trial.

5

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.

Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Camoriano JK, et al. Among authors: veeder mh. J Clin Oncol. 1990 Aug;8(8):1327-34. doi: 10.1200/JCO.1990.8.8.1327. J Clin Oncol. 1990. PMID: 2199619 Clinical Trial.

6

Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinoma.

Long HJ 3rd, Langdon RM Jr, Cha SS, Veeder MH, Pfeifle DM, Krook JE, Ebbert LP, Tschetter LK, Roshon SG. Long HJ 3rd, et al. Among authors: veeder mh. Gynecol Oncol. 1995 Aug;58(2):240-3. doi: 10.1006/gyno.1995.1217. Gynecol Oncol. 1995. PMID: 7622111 Clinical Trial.

7

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.

Cascino TL, Veeder MH, Buckner JC, O'Fallon JR, Wiesenfeld M, Levitt R, Goldberg RM, Kuross SA, Morton RF, Scheithauer BW. Cascino TL, et al. Among authors: veeder mh. J Neurooncol. 1996 Dec;30(3):243-6. doi: 10.1007/BF00177275. J Neurooncol. 1996. PMID: 8943099 Clinical Trial.

8

A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma.

Creagan ET, Twito DI, Johansson SL, Schaid DJ, Johnson PS, Flaum MA, Buroker TR, Geeraerts LH, Veeder MH, Gesme DH Jr, et al. Creagan ET, et al. Among authors: veeder mh. J Clin Oncol. 1991 Dec;9(12):2104-9. doi: 10.1200/JCO.1991.9.12.2104. J Clin Oncol. 1991. PMID: 1960551 Clinical Trial.

9

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.

Burch PA, Mailliard JA, Hillman DW, Perez EA, Krook JE, Rowland KM, Veeder MH, Cannon MW, Ingle JN. Burch PA, et al. Among authors: veeder mh. Am J Clin Oncol. 2005 Apr;28(2):195-200. doi: 10.1097/01.coc.0000144815.54746.d0. Am J Clin Oncol. 2005. PMID: 15803016 Clinical Trial.

10

Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.

Creagan ET, Suman VJ, Dalton RJ, Pitot HC, Long HJ, Veeder MH, Vukov AM, Rowland KM, Krook JE, Michalak JC. Creagan ET, et al. Among authors: veeder mh. J Clin Oncol. 1999 Jun;17(6):1884-90. doi: 10.1200/JCO.1999.17.6.1884. J Clin Oncol. 1999. PMID: 10561229 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters